🟣 The #StemCellEvidence alert - September 2026, is out!

🔗 See the link in the comments for the top 10 articles
#MedSky

🔗 #StemCellEvidence link to:
CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
by Silbert et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🟣 New from the #StemCellEvidence alert:

📑 CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results
by Silbert et al.

🔗 Link in the comments
#MedSky

🔗 #StemCellEvidence link to:
CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial
by Tang et al.
www.stemcellevidence.com/alerts/artic...
#MedSky

🆕 From the #StemCellEvidence alert:

📑 CMV-specific T-cell receptor-engineered T-cell therapy as first-line treatment for CMV reactivation after haploidentical hematopoietic stem cell transplantation: a phase 2 trial
by Tang et al.

🔗 Link in the comments
#MedSky